Researchers receive two grants to study tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024 – Biotech Investments

Rancho Cucamonga, 05/08/2024 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for

May 9, 2024

Adicet follows other cell therapy biotechs in autoimmune pivot

Adicet Bio is shelving plans to use its lead asset to treat cancer and instead shifting its target to autoimmune diseases. The move, disclosed by

September 11, 2024

New Study Reveals Microdosing Could Make You Feel More Authentic | Psychedelic Spotlight

Authentically expressing oneself is considered integral to personal fulfillment and wellbeing, and understanding the factors that contribute to this sense of authenticity is of great

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.